204840 — GL Pharm Tech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Market Cap
KR₩98bn
Enterprise Value
KR₩109bn
Revenue
KR₩26bn

Annual balance sheet for GL Pharm Tech, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	9,490	6,189	4,639	4,136	4,258
Net Total Accounts Receivable
Net Total Receivables	3,643	3,690	5,708	5,811	6,056
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	15,970	13,270	16,190	16,619	19,014
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	15,636	15,465	19,850	18,864	18,127
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	34,945	31,895	40,854	39,868	42,440
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	7,662	4,865	13,104	12,319	13,914
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	20,630	15,046	24,764	27,586	22,772
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Other Equity
Total Equity	14,315	16,849	16,090	12,282	19,668
Total Liabilities & Shareholders' Equity	34,945	31,895	40,854	39,868	42,440
Total Common Shares Outstanding
Total Preferred Shares Outstanding